This remains a “buy weakness” market. Sure, there are plenty of reasons for concern – which is almost always the case. But the positives continue to outweigh the negatives. So, I’m moderately bullish on stocks, particularly the ones that insiders favor.

Let’s start with three negatives.

It’s true that seasonal demand for certain foods and drinks—and the companies that produce them—is typically discounted well in advance by investors. Nonetheless, there’s evidence that interest in this category is picking up appreciably this summer.

My recent screening for turnaround candidates has picked up more than a few food and beverage companies that had fallen out of favor but are now attractive—and even showing signs of accumulation in some cases.

Despite the major indexes trading near the highs, most stocks have struggled.

For most of the rest of the market, the problem is oil. The price per barrel of crude oil skyrocketed to over $110 from under $60 before the war. And prices stayed elevated for more than three months. Oil is involved in everything. And that means inflation. And inflation means high interest rates.

But that’s in the past. The future is likely to be different.
Peace changes the dynamic. Without war, oil prices will fall. Interest rates will come down. That rate hike may be off the table. And stocks held back by inflation and high interest rates should be poised to move higher.

The pessimists have it all wrong. The resilient economy isn’t precarious. The restraints were precarious. When the falling oil prices unleash a stronger economy, it will change things. Let’s get ahead of the curve with stocks that will benefit.

Before we dive into this week’s covered call idea we need to move on from three stock positions coming out of June expiration, as the calls we sold expired worthless.

To execute these trades you need to:

Sell YOU stock

Sell PL stock

Sell VIAV stock

Moving on ...

Last week was a bit of a disjointed, volatile affair, so we’re being a bit more selective when it comes to stock selection and entry points. That said, the intermediate-term picture remains as bright as ever, with the trends for leading indexes, sectors and stocks pointed up and with impressive resilience and mostly-normal action even after many stocks posted massive gains in April and May. We’re leaving our Market Monitor at a level 8, aiming to give our winning stocks some rope and look for fresh buys on dips.

This week’s list is again heavy on growth names, though there are a few newer titles that haven’t appeared before. Our Top Pick is an out-of-the-way AI play that’s seeing humongous new orders and just completed a major acquisition.

Editor’s Note: There will be no issue of Cabot Stock of the Week next Monday. You will receive your next issue on Monday, July 6.

Rotation is in full swing, and that’s making for a healthier, less top-heavy market despite the S&P 500 and Nasdaq trading below their early-June tops. As the air has come out of the AI trade a bit, investors have simply moved money into the many unloved and undervalued sectors – financials, healthcare, utilities, materials. The latter sector is where today’s new portfolio addition comes from. It’s a little-known name Tyler Laundon dubbed his Top Pick in this month’s issue of his Cabot Early Opportunities newsletter. It’s a stock with tremendous upside and momentum.

Details inside.

After more than three months of dictating every move on Wall Street, the Iran war finally headed toward the exits last week — the U.S. and Iran agreed to a framework to end the conflict, reopen the Strait of Hormuz, and lift the U.S. naval blockade, sending oil tumbling back toward the mid-$70s. The other headliner last week was new Fed Chair Kevin Warsh’s first meeting on Wednesday: The Fed held rates steady, but its updated projections flipped hawkish, with the median policymaker now penciling in a rate hike rather than a cut before year-end — a shift that knocked stocks lower midweek before a sharp Thursday rebound.

After more than three months of dictating every move on Wall Street, the Iran war finally headed toward the exits last week — the U.S. and Iran agreed to a framework to end the conflict, reopen the Strait of Hormuz, and lift the U.S. naval blockade, sending oil tumbling back toward the mid-$70s. The other headliner last week was new Fed Chair Kevin Warsh’s first meeting on Wednesday: The Fed held rates steady, but its updated projections flipped hawkish, with the median policymaker now penciling in a rate hike rather than a cut before year-end — a shift that knocked stocks lower midweek before a sharp Thursday rebound.

After more than three months of dictating every move on Wall Street, the Iran war finally headed toward the exits last week — the U.S. and Iran agreed to a framework to end the conflict, reopen the Strait of Hormuz, and lift the U.S. naval blockade, sending oil tumbling back toward the mid-$70s. The other headliner last week was new Fed Chair Kevin Warsh’s first meeting on Wednesday: The Fed held rates steady, but its updated projections flipped hawkish, with the median policymaker now penciling in a rate hike rather than a cut before year-end — a shift that knocked stocks lower midweek before a sharp Thursday rebound.

It was a better week for markets and Explorer stocks. GE Vernova (GEV) came to life this week, up 21%. Coeur Mining (CDE) shares rebounded this week, soaring 13.8% following a recent announcement that it will be added to the S&P MidCap 400 Index.

And new Fed chairman Kevin Warsh signaled yesterday that he is an inflation hawk. Overnight, the Bank of Japan raised interest rates to its highest level since 1995. Officials signaled more hikes ahead to combat too-high inflation.

But our bull market seems to confirm that rising interest rates do not matter much.

The June issue of Cabot Early Opportunities is focused on three companies benefiting from powerful structural growth trends that are still in the early innings.

Whether it’s a newly independent materials company gaining exposure to nuclear and AI demand, a critical power infrastructure provider solving bottlenecks in next-generation computing, or a semiconductor supplier riding a surge in testing complexity, these businesses are seeing improving fundamentals that continue to pull in fresh money.

All the details are in the June issue of Cabot Early Opportunities.

What a difference a week makes. After the prior Friday’s chip-driven rout, a volatile, headline-whipped week ultimately ended higher as growing optimism that a U.S.-Iran peace deal is finally within reach sent oil tumbling back toward $85 a barrel. And despite a modestly hot May inflation report and an Oracle-led wobble in AI names, by Friday the bulls had the upper hand as SpaceX pulled off the largest IPO in history.

June has been a return to form for stocks in 2026, with value outperforming growth the way it did in the first quarter before the April and May AI-fueled boom. This month, value stocks are up roughly 3% while the S&P 500 is down 2.5% and the Nasdaq is off more than 4%. That mimics the first-quarter outperformance by value stocks, which added 2.5% from January through March while the S&P and Nasdaq tumbled 4.5% and 7%, respectively.

Small caps just passed their Fed test – and continue to hold up well.

The S&P 600 SmallCap Index is up about 2.5% since last Thursday’s close and up 4.2% since last Wednesday’s close (the day of the FOMC meeting). The index is trading at an all-time high this morning.

A sharp selloff in chip stocks rattled markets this week but the AI buildout and AI demand are moving at a breakneck speed and the cost to run AI models seems to be going down.

In short, confusion reigns as AI costs are weighed against potential returns. The backdrop is that stocks of most of the chip companies have had crazy runs so a sharp pullback was inevitable. Taiwan and South Korean stocks have been particularly volatile.

The peace rally is again being overshadowed by more technology ugliness.

The selloff in artificial intelligence that began after Broadcom’s (AVGO) earnings at the beginning of the month is gaining steam early this week. Technology had been red-hot and lifted the market in April and May. Now, it’s spoiling the peace party.

Has there ever been anything as overvalued as SpaceX (SPCX)?

Elon Musk’s rocket and space-based internet company reported $18.7 billion in revenue in 2025. That’s less than half the revenue declining electronics store chain Best Buy (BBY, $41.7 billion) generated last year, less than International Paper Company (IP, $23.6 billion), and barely more than Casey’s General Stores (CASY, $17.6 billion). Those three companies have a combined market cap of roughly $67 billion. As of this writing, SpaceX has a market cap of $2.7 trillion. That’s more than the combined market cap of Walmart (WMT), JPMorgan (JPM) and Visa (V). Together, those three companies generated $847 billion in revenue last year.

Small caps continue to hold up well. The S&P 600 Small Cap Index is up modestly since last Thursday and is trading just below the fresh all-time highs it hit earlier this week. The group’s resilience stands out, especially against a backdrop of narrowing leadership and ongoing rotation beneath the market’s surface.

The main macro development this week was the Fed’s June meeting and Chair Kevin Warsh’s press conference, which confirmed a shift in policy direction.

WHAT TO DO NOW: The market’s bounce has been a good one, and the intermediate-term outlook remains bright. That said, near term, there are still some crosscurrents (rotation into the broad market, Dow outperforming the Nasdaq) that tell us growth stocks could throw us another curveball in the coming week or two. Overall, then, we’re mostly standing pat, but we’re going to add a half-sized stake in Guardant Health (GH) here, leaving us with a still-good-sized cash position of 37% or so. Details below.

Stocks started this week with a huge rally as the Iran ceasefire deal appears to be the real thing.

Of course, it’s been months of supposed peace deals falling apart. It’s hard to believe. I’m sure that fact is holding the market back somewhat. But this one is different for a couple of reasons.

Stocks are starting off this week with a huge rally as the U.S. and Iran have reached a ceasefire deal.

We’ve been here before. These peace deals have fallen apart several times. I’m sure that fact is holding the market back somewhat. But this one is different for a couple of reasons. First, it’s the furthest a peace deal has gotten with both sides agreeing and independent verification from Pakistan. Second, this is what a peace deal would look like at this point if it’s real and lasting.

[Note: The Cabot Turnaround Letter weekly update won’t be published next Friday, June 19, due to the market being closed for the Juneteenth holiday.]

Before we get into the main topic for today’s newsletter update, a quick note on the portfolio is in order. I’m continuing our “spring cleaning” effort that we began last week by trimming a couple more of our holdings, but I’m also adding a new position to take the place of the recent deletions.

After two near-record-setting months, stocks are encountering their first real turbulence since March. It’s no surprise.

While stocks go up an average of 10% a year, they rarely do so in a straight line. And after the S&P 500 rallied nearly 20% in April and May and the Nasdaq shot up nearly 30%, a pullback of some kind – or possibly even a true correction – was to be expected. It seems it’s happening all at once.

Stocks look set to enter the summer near all-time highs, but leadership has narrowed, volatility has ticked up, and there’s been renewed scrutiny on the AI trade and valuation concerns in some of the market’s biggest winners.

At the same time, the macro backdrop remains a mix of resilience and intermittent turbulence. While economic data continues to hold up, energy prices remain elevated due to the ongoing Iran conflict – which has no end in sight – keeping upward pressure on inflation and yields.

This new small-cap fund has risen almost 17% since its launch in December. It may be appropriate for more aggressive, risk-oriented investors.

Baron Discovery (BDFFX)
from The No-Load Fund Investor

Baron Discovery (BDFFX) was launched in September. The fund is managed by Laird Bieger and Randy Gwirtzman, who joined BaronAssetManagement as equity analysts...

This education provider just topped earnings estimates by 11 cents, and Piper Jaffray upgraded its shares to “outperform”. The recent pullback provides an opportunity to buy in.

DeVry Education Group
from Shortex


DeVry Education (DV)
TODAY’S PRICE: $45.03
52-week High: 47.73 52-week Low: 27.04
Market Cap: $2.81B, EPS $1.00, P/E: 44.34

DeVry is a global provider...

This semiconductor manufacturer beat its earnings estimate by seven cents and brokerage firm Jefferies recently raised its price target to $72.

NXP Semiconductors NV (NXPI)
from Blue Chip Growth

During the first weeks in April, the market wasn’t kind to momentum stocks. So it really speaks to the quality of a stock when...

This tech company is on the radar of Wall Street, where analysts have recently upgraded its shares and raised its price target to $90 per share.

Synaptics (SYNA)
from Upside

Synaptics (SYNA) shares have delivered a 16% total return this year yet trade at just 14 times trailing earnings—35% below the average for...

This biotech company just completed a successful Phase 2 clinical trial for its respiratory illness vaccine for women of childbearing age. Please note that shares of biotech companies are speculative in nature and should be allocated to a small percentage of your overall portfolio.

Novavax (NVAX)
from The Medical Technology Stock Letter

Novavax...

This oil refiner had a great quarter, with profits up 27%, handily beating analyst estimates.

Valero Energy (VLO)
from Energy Strategist

Energy stocks have been red-hot of late, leading the stock market toward new records even as surging domestic production adds to the crude glut on the Gulf Coast. We’re taking the opportunity...

This digital software and hardware company just added a former top executive at Apple to its board of directors.

Pixelworks, Inc. (PXLW)
from the Oberweis Report

Pixelworks (PXLW) designs, develops and markets video and pixel processing semiconductors, intellectual property cores, software, and custom ASIC solutions for high-end digital video applications. The company’s products...

According to Zack’s this dairy-based nutritional company has recently entered oversold territory.

Synutra International (SYUT)
from The Value Bounce

Sharply rising incomes across the emerging world has created surging demand for protein—and this means there is big money in meat and dairy. Demand for butter, whole-milk powder and fresh milk products will grow...

It looks like biotechs may be making a rebound, which may garner a closer look at this closed-end fund.

H&Q Healthcare Investors (HQH)
from Investor’s Edge

H&Q Healthcare Investors (HQH) top 5 holdings are Gilead Sciences, Celgene, Regeneron Pharmaceuticals, Biogen Idec, Alexion Pharmaceuticals, and Amgen, all giants in the healthcare/biotech field.

In addition to...

This global insurance provider recently hiked its dividend by $0.35 and also received a Strong Buy rating from Zack’s.

Allied World Assurance (AWH)
from 2 for 1

Allied World Assurance (AWH) splitting 3 for 1 wins the pole position and will be added to the 2 for 1 portfolio next week.

Allied is a...

BUY IDEAS
from Investor’s Intelligence

Barnes Group (B)

This industrial and aerospace manufacturer just beat analysts’ earnings forecasts by $0.05.

Barnes Group (B) rose 1.7% on Thursday, outperforming. The relative chart is moving up from the lower end of a medium-term range. Further outperformance likely, with a test of the record price high from...

A possible spin-off, supported by a termination of the stock buyback program, and an SEC rule requiring an index change, have combined to price this BDC at a discount.

American Capital (ACAS)
from Adrian Day’s Global Analyst

American Capital (ACAS) announced it would suspend indefinitely its buy-back program amid an evaluation on restructuring...

A few Cabot Options Trader subscribers have asked me about ways to protect gains in their portfolios, so I thought I would write to everyone with a couple of strategies using options to hedge your portfolio.

A subscriber recently asked me if I keep a journal of my trades. Many traders keep journals so they can look back at their trades and evaluate what they did right and what they did wrong.

Want to know how the big institutional investors use options? Here is an example of how one trader spent $132 million on three technology stocks.

Options trading has its own vernacular. To know how to do it, you need to know what every options term means. Here are some of the basics.

Our Cabot Top Ten Trader’s market timing system consists of two parts—one based on the action of three select, growth-oriented market indexes, and the other based on the action of the fast-moving stocks Cabot Top Ten features.